annual EBIT:
$195.12M+$108.31M(+124.77%)Summary
- As of today (June 26, 2025), CPRX annual earnings before interest & taxes is $195.12 million, with the most recent change of +$108.31 million (+124.77%) on December 31, 2024.
- During the last 3 years, CPRX annual EBIT has risen by +$142.74 million (+272.48%).
- CPRX annual EBIT is now at all-time high.
Performance
CPRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$63.37M+$524.00K(+0.83%)Summary
- As of today (June 26, 2025), CPRX quarterly earnings before interest & taxes is $63.37 million, with the most recent change of +$524.00 thousand (+0.83%) on March 31, 2025.
- Over the past year, CPRX quarterly EBIT has increased by +$36.24 million (+133.60%).
- CPRX quarterly EBIT is now at all-time high.
Performance
CPRX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$231.37M+$36.24M(+18.57%)Summary
- As of today (June 26, 2025), CPRX TTM earnings before interest & taxes is $231.37 million, with the most recent change of +$36.24 million (+18.57%) on March 31, 2025.
- Over the past year, CPRX TTM EBIT has increased by +$153.04 million (+195.38%).
- CPRX TTM EBIT is now at all-time high.
Performance
CPRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CPRX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +124.8% | +133.6% | +195.4% |
| 3 y3 years | +272.5% | +264.9% | +285.9% |
| 5 y5 years | +513.1% | +492.2% | +431.7% |
CPRX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +272.5% | at high | +270.4% | at high | +285.9% |
| 5 y | 5-year | at high | +513.1% | at high | +270.4% | at high | +472.6% |
| alltime | all time | at high | +652.8% | at high | +270.4% | at high | +755.5% |
CPRX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $63.37M(+0.8%) | $231.37M(+18.6%) |
| Dec 2024 | $195.12M(+124.8%) | $62.84M(+23.4%) | $195.12M(+12.2%) |
| Sep 2024 | - | $50.91M(-6.2%) | $173.97M(+102.6%) |
| Jun 2024 | - | $54.25M(+100.0%) | $85.88M(+9.6%) |
| Mar 2024 | - | $27.13M(-34.9%) | $78.33M(-9.8%) |
| Dec 2023 | $86.81M(-14.8%) | $41.69M(-212.1%) | $86.81M(+14.3%) |
| Sep 2023 | - | -$37.19M(-179.6%) | $75.92M(-45.1%) |
| Jun 2023 | - | $46.70M(+31.1%) | $138.21M(+15.1%) |
| Mar 2023 | - | $35.61M(+15.6%) | $120.08M(+17.9%) |
| Dec 2022 | $101.84M(+94.4%) | $30.80M(+22.7%) | $101.84M(+21.6%) |
| Sep 2022 | - | $25.10M(-12.1%) | $83.78M(+15.3%) |
| Jun 2022 | - | $28.57M(+64.5%) | $72.68M(+21.2%) |
| Mar 2022 | - | $17.37M(+36.3%) | $59.95M(+14.4%) |
| Dec 2021 | $52.38M(+26.8%) | $12.74M(-9.0%) | $52.38M(+8.5%) |
| Sep 2021 | - | $14.00M(-11.6%) | $48.26M(+5.0%) |
| Jun 2021 | - | $15.84M(+61.6%) | $45.96M(+13.8%) |
| Mar 2021 | - | $9.80M(+13.7%) | $40.41M(-2.2%) |
| Dec 2020 | $41.30M(+29.8%) | $8.62M(-26.4%) | $41.30M(+1.5%) |
| Sep 2020 | - | $11.70M(+13.8%) | $40.69M(-5.0%) |
| Jun 2020 | - | $10.28M(-3.9%) | $42.83M(-1.6%) |
| Mar 2020 | - | $10.70M(+33.6%) | $43.51M(+36.7%) |
| Dec 2019 | $31.82M(-190.2%) | $8.01M(-42.2%) | $31.82M(+254.6%) |
| Sep 2019 | - | $13.85M(+26.3%) | $8.97M(-168.7%) |
| Jun 2019 | - | $10.96M(-1209.5%) | -$13.05M(-57.0%) |
| Mar 2019 | - | -$987.80K(-93.3%) | -$30.35M(-14.0%) |
| Dec 2018 | -$35.30M(+89.0%) | -$14.84M(+81.4%) | -$35.30M(+35.9%) |
| Sep 2018 | - | -$8.18M(+29.1%) | -$25.96M(+17.5%) |
| Jun 2018 | - | -$6.34M(+6.8%) | -$22.09M(+10.8%) |
| Mar 2018 | - | -$5.93M(+7.6%) | -$19.93M(+6.7%) |
| Dec 2017 | -$18.68M(-3.1%) | -$5.51M(+28.0%) | -$18.68M(+6.9%) |
| Sep 2017 | - | -$4.31M(+3.0%) | -$17.48M(+2.3%) |
| Jun 2017 | - | -$4.18M(-10.7%) | -$17.09M(-3.6%) |
| Mar 2017 | - | -$4.68M(+8.5%) | -$17.72M(-8.1%) |
| Dec 2016 | -$19.28M(-5.5%) | -$4.31M(+10.2%) | -$19.28M(-8.9%) |
| Sep 2016 | - | -$3.91M(-18.7%) | -$21.16M(-5.0%) |
| Jun 2016 | - | -$4.81M(-22.8%) | -$22.26M(-0.4%) |
| Mar 2016 | - | -$6.24M(+0.7%) | -$22.34M(+9.5%) |
| Dec 2015 | -$20.40M(+39.8%) | -$6.19M(+23.4%) | -$20.40M(+12.1%) |
| Sep 2015 | - | -$5.02M(+2.5%) | -$18.19M(+5.3%) |
| Jun 2015 | - | -$4.90M(+14.1%) | -$17.28M(+12.4%) |
| Mar 2015 | - | -$4.29M(+7.7%) | -$15.38M(+5.4%) |
| Dec 2014 | -$14.59M | -$3.98M(-3.0%) | -$14.59M(+9.6%) |
| Sep 2014 | - | -$4.11M(+37.4%) | -$13.31M(+6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | -$2.99M(-14.8%) | -$12.45M(+2.8%) |
| Mar 2014 | - | -$3.51M(+29.6%) | -$12.11M(+17.5%) |
| Dec 2013 | -$10.31M(+97.5%) | -$2.71M(-16.6%) | -$10.31M(+13.2%) |
| Sep 2013 | - | -$3.25M(+22.3%) | -$9.11M(+27.4%) |
| Jun 2013 | - | -$2.65M(+55.6%) | -$7.15M(+28.5%) |
| Mar 2013 | - | -$1.71M(+13.3%) | -$5.56M(+6.5%) |
| Dec 2012 | -$5.22M(-14.2%) | -$1.51M(+17.3%) | -$5.22M(-9.2%) |
| Sep 2012 | - | -$1.28M(+20.3%) | -$5.75M(+2.7%) |
| Jun 2012 | - | -$1.07M(-21.8%) | -$5.60M(-5.6%) |
| Mar 2012 | - | -$1.36M(-32.9%) | -$5.93M(-2.5%) |
| Dec 2011 | -$6.08M(+51.1%) | -$2.03M(+79.9%) | -$6.08M(+27.2%) |
| Sep 2011 | - | -$1.13M(-19.1%) | -$4.78M(+4.9%) |
| Jun 2011 | - | -$1.40M(-8.0%) | -$4.56M(+1.4%) |
| Mar 2011 | - | -$1.52M(+107.5%) | -$4.49M(+11.6%) |
| Dec 2010 | -$4.02M(-44.7%) | -$732.20K(-19.4%) | -$4.02M(-9.8%) |
| Sep 2010 | - | -$908.50K(-31.9%) | -$4.46M(-7.9%) |
| Jun 2010 | - | -$1.33M(+26.9%) | -$4.85M(-8.3%) |
| Mar 2010 | - | -$1.05M(-10.2%) | -$5.28M(-27.4%) |
| Dec 2009 | -$7.28M(-33.2%) | -$1.17M(-9.5%) | -$7.28M(-26.5%) |
| Sep 2009 | - | -$1.29M(-26.9%) | -$9.90M(-14.1%) |
| Jun 2009 | - | -$1.77M(-41.9%) | -$11.52M(-5.7%) |
| Mar 2009 | - | -$3.04M(-19.7%) | -$12.21M(+12.1%) |
| Dec 2008 | -$10.89M(+116.7%) | -$3.79M(+30.1%) | -$10.89M(+32.1%) |
| Sep 2008 | - | -$2.91M(+18.3%) | -$8.25M(+31.3%) |
| Jun 2008 | - | -$2.46M(+42.9%) | -$6.28M(+19.5%) |
| Mar 2008 | - | -$1.72M(+50.9%) | -$5.25M(+4.5%) |
| Dec 2007 | -$5.03M(+73.2%) | -$1.14M(+20.2%) | -$5.03M(+5.4%) |
| Sep 2007 | - | -$950.40K(-33.9%) | -$4.77M(-7.6%) |
| Jun 2007 | - | -$1.44M(-4.0%) | -$5.16M(+26.5%) |
| Mar 2007 | - | -$1.50M(+69.1%) | -$4.08M(+39.9%) |
| Dec 2006 | -$2.90M(+59.3%) | -$885.20K(-34.0%) | -$2.92M(-13.0%) |
| Sep 2006 | - | -$1.34M(+276.0%) | -$3.35M(+48.8%) |
| Jun 2006 | - | -$357.00K(+7.1%) | -$2.25M(-11.9%) |
| Mar 2006 | - | -$333.40K(-74.8%) | -$2.56M(-11.3%) |
| Dec 2005 | -$1.82M(+235.6%) | -$1.32M(+446.4%) | -$2.89M(+69.9%) |
| Sep 2005 | - | -$241.90K(-63.4%) | -$1.70M(+6.7%) |
| Jun 2005 | - | -$660.80K(0.0%) | -$1.59M(+49.3%) |
| Mar 2005 | - | -$660.80K(+389.5%) | -$1.07M(+97.4%) |
| Dec 2004 | -$543.00K(+26.7%) | -$135.00K(0.0%) | -$540.00K(+33.3%) |
| Sep 2004 | - | -$135.00K(0.0%) | -$405.00K(+50.0%) |
| Jun 2004 | - | -$135.00K(0.0%) | -$270.00K(+100.0%) |
| Mar 2004 | - | -$135.00K | -$135.00K |
| Dec 2003 | -$428.60K(+67.5%) | - | - |
| Dec 2002 | -$255.90K | - | - |
FAQ
- What is Catalyst Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual EBIT year-on-year change?
- What is Catalyst Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly EBIT year-on-year change?
- What is Catalyst Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals TTM EBIT year-on-year change?
What is Catalyst Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of CPRX is $195.12M
What is the all time high annual EBIT for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual earnings before interest & taxes is $195.12M
What is Catalyst Pharmaceuticals annual EBIT year-on-year change?
Over the past year, CPRX annual earnings before interest & taxes has changed by +$108.31M (+124.77%)
What is Catalyst Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of CPRX is $63.37M
What is the all time high quarterly EBIT for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly earnings before interest & taxes is $63.37M
What is Catalyst Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, CPRX quarterly earnings before interest & taxes has changed by +$36.24M (+133.60%)
What is Catalyst Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of CPRX is $231.37M
What is the all time high TTM EBIT for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high TTM earnings before interest & taxes is $231.37M
What is Catalyst Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, CPRX TTM earnings before interest & taxes has changed by +$153.04M (+195.38%)